Profil
Yves Sagot was the founder of RELIEF THERAPEUTICS Holding SA, founded in 2013, and served as Chief Scientific Officer from 2016 to 2020.
Dr. Sagot is also the founder of Sonnet BioTherapeutics CH SA..
Dr. Sagot was an Independent Director at BioSenic SA. Dr. Sagot completed graduate and doctorate degrees at the University of Geneva and a doctorate degree at Université Toulouse III - Paul Sabatier.
Anciens postes connus de Yves Sagot
| Sociétés | Poste | Fin |
|---|---|---|
| MINDMAZE THERAPEUTICS HOLDING SA | Fondateur | 08/10/2020 |
| BIOSENIC SA | Directeur/Membre du Conseil | - |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Manufactures drugs for peripheral neuropathies | Fondateur | - |
Formation de Yves Sagot
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Geneva
University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Toulouse III - Paul Sabatier
Université Toulouse III - Paul Sabatier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Manufactures drugs for peripheral neuropathies | Health Technology |
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
BioSenic SA
BioSenic SA BiotechnologyHealth Technology Engages in medical research and develops drugs | Health Technology |
















